ESMO 2026 has ended. This guide stays up as the record of who was there. Next: ESMO 2027, Sep 17–21, 2027 in Barcelona

EK

Evangelische Kliniken Essen-Mitte at ESMO 2026

Oct 23–27, 2026 Madrid, Spain ~37k attendees Website

Evangelische Kliniken Essen-Mitte takes part in 4 sessions at ESMO 2026 in Madrid. Its sessions focus on breast and gynaecological cancers, including treatment decisions for early breast cancer. They examine how prior chemotherapy relates to patient profiles and discuss tailoring surgery under the arm and hormone therapy after surgery.

OrganizationESMO 2026 Attendance
EK
Evangelische Kliniken Essen-Mitte
Essen, Germany
Cancer centre & hospital
Protestant non-profit hospital group in central Essen, Germany.
Chair
Sat Oct 24
08:30–10:00
Rapid oral 2: Gynaecological cancers
with University Hospitals Leuven, Policlinico Universitario Agostino Gemelli
Gynaecological cancers
Abstract
Sat Oct 24
08:40–08:52
Invited Discussant LBA40 and 1245RO
Rapid oral 2: Gynaecological cancers
Gynaecological cancers
Satellite
Sat Oct 24
18:30–18:40
Welcome and Introduction
Eli Lilly and Company - Navigating the Therapeutic Crossroads in HR+ HER2- Breast Cancer: Defining Your Next Clinical Decision
Breast cancer
Satellite
Sat Oct 24
18:55–19:05
Interactive panel discussion
Eli Lilly and Company - Navigating the Therapeutic Crossroads in HR+ HER2- Breast Cancer: Defining Your Next Clinical Decision · with Dana-Farber Cancer Institute, Latin American Cooperative Oncology Group
Breast cancer
Satellite
Sat Oct 24
19:20–19:30
Interactive panel discussion
Eli Lilly and Company - Navigating the Therapeutic Crossroads in HR+ HER2- Breast Cancer: Defining Your Next Clinical Decision · with Latin American Cooperative Oncology Group, Dana-Farber Cancer Institute
Breast cancer
Satellite
Sat Oct 24
19:30–19:40
What Does the Future Hold for Adjuvant Endocrine Therapy? The Road Ahead
Eli Lilly and Company - Navigating the Therapeutic Crossroads in HR+ HER2- Breast Cancer: Defining Your Next Clinical Decision
Breast cancer
Satellite
Sat Oct 24
19:40–19:50
Interactive panel discussion
Eli Lilly and Company - Navigating the Therapeutic Crossroads in HR+ HER2- Breast Cancer: Defining Your Next Clinical Decision · with Dana-Farber Cancer Institute, Latin American Cooperative Oncology Group
Breast cancer
Talk
Sun Oct 25
09:30–09:50
Tailoring axillary management
Personalising treatment for patients with early stage HR+ breast cancer
Breast cancer

Explore the full ESMO 2026 dataset

Get in-depth attendee and institution profiles and research, to plan your meetings in Madrid. Leave your work email and we’ll be in touch.

Privacy

Download the full ESMO 2026 CSV

Leave your work email and we’ll be in touch. The CSV adds attendee names, roles and contact details to the company and session data shown here.

Privacy

Find decision makers at Evangelische Kliniken Essen-Mitte

Tell us what you sell and we’ll find the people at Evangelische Kliniken Essen-Mitte most likely to buy it.

  • Who to contact
  • Their contact info
  • What to say
  • Free, no sign-up

Not affiliated with or endorsed by the European Society for Medical Oncology. Submit a correction